Rosuvastatin Calcium/Metformin Hydrochloride

็‘ž่ˆ’ไผไป–ๆฑ€้’™/็›้…ธไบŒ็”ฒๅŒ่ƒ

Report date: 2024/02/01 20:01:00

Base Information

Drug NameRosuvastatin Calcium/Metformin Hydrochloride
Drug Alias Name็›้…ธไบŒ็”ฒๅŒ่ƒ/็‘ž่ˆ’ไผไป–ๆฑ€้’™Rosuvastatin Calcium and Metformin Hydrochloride็›้…ธไบŒ็”ฒๅŒ่ƒ็‘ž่ˆ’ไผไป–ๆฑ€้’™Metformin hydrochloride/rosuvastatin calciumMetformin hydrochloride and rosuvastatin calcium +[9]ย 
ClassificationSmall molecules
Mechanisms of ActionHMG-CoA reductase inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsProtein kinase AMP-activated non-catalytic subunit beta 1HMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasDyslipidemiasDiabetes Mellitus, Type 2 +[4]ย 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes Metformin HydrochlorideRosuvastatin Calcium
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJeil Pharmaceutical Co LtdYuhan Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co LtdJeil Pharmaceutical Co LtdYuhan Corp
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasDyslipidemiasDiabetes Mellitus, Type 2 +[4]ย 

Other Information

ATC CodeN/A
Related LinksN/A